Preview

Current Pediatrics

Advanced search

Combination of Schaaf - Yang Syndrome with Unspecified Hyperammonemia in a Newborn: Case Study

https://doi.org/10.15690/vsp.v24i5.2976

Abstract

Backround. Combined pathology of primary genetic disease and rare secondary disorders presents the most diagnostical difficulties for neonatologist. Such are atypical signs of Schaaf - Yang syndrome in newborns. Case description. The premature baby was diagnosed in utero with fingers abnormality. Genetic disorder was suspected at birth due to multiple stigmas (shortened limbs, multiple joint contractures, finger deformity, cryptorchidism). Whereas severe respiratory, hemodynamic, convulsive and motor disorders, as well as pseudobulbar syndrome were regarded as manifestations of congenital pneumonia and perinatal injury of the central nervous system. Hyperammonemia was revealed at the 2nd month of life and it was regarded as secondary condition associated with combined hereditary and perinatal pathology. Any chromosome aberrations, hereditary aminoacidopathies, organic aciduria, mitochondrial diseases were excluded via multi-stage diagnostic search using karyotyping, tandem mass-spectrometry, determination of glycine concentration ratio in cerebrospinal fluid and blood. Whole-exome sequencing of the child’s DNA revealed pathogenic variant in the MAGEL2 gene in a heterozygous state (rs770374710) at the age of 3 months. This variant leads to frameshifting and premature protein translation. There were no pathological variants in the parents, thus, the patient had de novo mutation. Since there is no etiopathogenetic therapy for this disease, the patient received only syndromic therapy. Conclusion. This case demonstrates diagnostic challenges in comorbid genetic syndrome and perinatal pathology and unspecified hyperammonemia.

About the Authors

Irina A. Belyaeva
Morozovskaya Children's City Hospital; Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
Russian Federation

Moscow


Disclosure of interest:

Irina A. Belyaeva — lecturing for pharmaceutical
companies JSC Progress, Bayer, AstraZeneca, Abbott
Laboratories, HIROW RUS, SweetMil



Elena O. Kurnatovskaya
Morozovskaya Children's City Hospital
Russian Federation

Moscow


Disclosure of interest:

Authors confirmed the absence of a reportable
conflict of interest.



Vera V. Zarubina
Morozovskaya Children's City Hospital
Russian Federation

Moscow


Disclosure of interest:

Authors confirmed the absence of a reportable
conflict of interest.



Andrey Yu. Kruglyakov
Morozovskaya Children's City Hospital
Russian Federation

Moscow


Disclosure of interest:

Authors confirmed the absence of a reportable
conflict of interest.



Totuy K. Eldarova
Morozovskaya Children's City Hospital
Russian Federation

Moscow


Disclosure of interest:

Authors confirmed the absence of a reportable
conflict of interest.



Mikhail M. Kamenev
Morozovskaya Children's City Hospital
Russian Federation

Moscow


Disclosure of interest:

Authors confirmed the absence of a reportable
conflict of interest.



References

1. McCarthy J, Lupo PJ, Kovar E, et al. Schaaf-Yang syndrome overview: Report of 78 individuals. Am J Med Genet A. 2018; 176(12): 2564-25 74. doi: https://doi.org/10.1002/ajmg.a.40650

2. Schubert T, Schaaf CP MAGEL2 (patho-)physiology and Schaaf- Yang syndrome. Dev Med Child Neurol. 2025;67(1):35-48. doi: https://doi.org/10.1111/dmcn.16018

3. Schaaf CP, Marbach F. Schaaf-Yang Syndrome. 2021 Feb 11 [updated 2021 Nov 4. In: GeneReviews [Internet. Adam MP, Feldman J, Mirzaa GM, eds. Seattle (WA): University of Washington, Seattle; 1993-2025.

4. Huang Z, Lu W, Zhang P, et al. Early onset critically ill infants with Schaaf-Yang syndrome: a retrospective study from the China neonatal genomes project and literature review. Ann Transl Med. 2023;11(9):312. doi: https://doi.org/10.21037/atm-22-4396

5. Dadali EL, Markova TV, Bostanova FM, et al. Special clinical manifestations and genetic characteristics of Schaaf-Yang syndrome in Russian patients. Nervno-myshechnye bolezni = Neuromuscular Diseases. 2024;14(1):42-50. (In Russ). doi: https://doi.org/10.17650/2222-8721-2024-14-1-42-50

6. Grigorchuk SE, Turkina OS, Chekmareva NYu. Prenatal ultrasound diagnosis of Schaaf-Young syndrome. Voprosy ginekologii, akusherstva i perinatologii = Gynecology, Obstetrics and Perinatology. 2024;23(1):132-134. (In Russ). doi: https://doi.org/10.20953/1726-1678-2024-1-132-134

7. Gumenyuk OI, Martynova VV, Rudneva TA, Chernenkov YuV. Sindrom Shaafa-Yang (klinicheskii sluchai). Bulletin of Medical Internet Conferences. 2024;14(7-8):71. (In Russ).

8. Schaaf CP Gonzalez-Garay ML, Xia F, et al. Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet. 2013;45(11):1405-1408. doi: https://doi.org/10.1038/ng.2776

9. Crutcher E, Pal R, Naini F, et al. mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome. Sci Rep. 2019;9(1):15935. doi: https://doi.org/10.1038/s41598-019-52287-2

10. Chen X, Ma X, Zou C. Phenotypic spectrum and genetic analysis in the fatal cases of Schaaf-Yang syndrome: Two case reports and literature review. Medicine (Baltimore). 2020;99(29):e20574. doi: https://doi.org/10.1097/MD.0000000000020574

11. Schaaf-Yang Syndrome (SHFYNG). In: MalaCards: The Human Disease Database. Available online: https://www.malacards.org/card/schaaf_yang_syndrome. Accessed on November 20, 2025.

12. MaaG JG, Brennenstuhl H, Schaaf CP. Morbidity and mortality in Schaaf-Yang syndrome. Ann Transl Med. 2023;11(12):405. doi: https://doi.org/10.21037/atm-23-1718

13. Castilla-Vallmanya L, Centeno-Pla M, Serrano M, et al. Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2. J Med Genet. 2023;60(4):406-415. doi: https://doi.org/10.1136/jmg-2022-108690

14. Juriaans AF, Kerkhof GF, Garrelfs M, et al. Schaaf-Yang Syndrome: Clinical Phenotype and Effects of 4 years of Growth Hormone Treatment. Horm Res Paediatr. 2024;97(2):148-156. doi: https://doi.org/10.1159/000531629

15. Kanna E, Batsari E, Lamprinou Z, et al. Laparoscopic Treatment of Severe Gastroesophageal Reflux Disease (GERD) in Schaaf- Yang Syndrome: First Report of Toupet Fundoplication. Cureus. 2025;17(7):e87726. doi: https://doi.org/10.7759/cureus.87726

16. Mari A, Sartorio MUA, Degrassi I, et al. Late-Onset Pyloric Stenosis and Intussusception With Final Diagnosis of Food Proteins' Hypersensitivity in Schaaf-Yang Syndrome: A Case Report. JPGN Rep. 2022;3(2):e202. doi: https://doi.org/10.1097/PG9.0000000000000202

17. Fountain MD, Aten E, Cho MT, et al. The phenotypic spectrum of Schaaf-Yang syndrome: 18 new affected individuals from 14 families. Genet Med. 2017;19(1):45-52. doi: https://doi.org/10.1038/gim.2016.53

18. Mejlachowicz D, Nolent F, Maluenda J, et al. Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis. Am J Hum Genet. 2015;97(4):616-620. doi: https://doi.org/10.1016/j.ajhg.2015.08.010

19. Ahn H, Seo GH, Oh A, et al. Diagnosis of Schaaf-Yang syndrome in Korean children with developmental delay and hypotonia. Medicine (Baltimore). 2020;99(51):e23864. doi: https://doi.org/10.1097/MD.0000000000023864

20. Hebach NR, Caro P Martin-Giacalone BA, et al. A retrospective analysis of growth hormone therapy in children with Schaaf-Yang syndrome. Clin Genet. 2021;100(3):298-307. doi: https://doi.org/10.1111/cge.14000


Review

For citations:


Belyaeva I.A., Kurnatovskaya E.O., Zarubina V.V., Kruglyakov A.Yu., Eldarova T.K., Kamenev M.M. Combination of Schaaf - Yang Syndrome with Unspecified Hyperammonemia in a Newborn: Case Study. Current Pediatrics. 2025;24(5):384-391. (In Russ.) https://doi.org/10.15690/vsp.v24i5.2976

Views: 9


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)